WHO expands options for HPV vaccination with Cecolin

FHS
October 7, 2024
10:37 am

WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The

Sanofi hires Mike Quigley as next chief scientist, internal memo says

Sanofi has appointed Mike Quigley, a former executive at Gilead and Bristol Myers Squibb, as the French pharma’s next chief scientific officer, Endpoints News …

September 25, 2024

The Supreme Court will consider state bans on gender-affirming care for minors

WASHINGTON — The Supreme Court on Monday jumped into the fight over transgender rights, agreeing to hear an appeal from the Biden administration seeking to block state

June 24, 2024

New study unveils why glioblastoma becomes resistant to treatment

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain

November 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.